PTJ
INSY

Paul Tudor Jones’s Insys Therapeutics, Inc. INSY Stock Holding History

Paul Tudor Jones’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-25,263
Closed -$88K – 1347
2018
Q4 		$88K Buy
+25,263
New +$176K ﹤0.01% 932
2017
Q3 		– Sell
-11,767
Closed -$149K – 1337
2017
Q2 		$149K Sell
11,767
-37,822
-76% -$448K ﹤0.01% 926
2017
Q1 		$521K Buy
49,589
+7,184
+17% +$76.5K 0.02% 659
2016
Q4 		$390K Buy
42,405
+29,007
+217% +$328K 0.01% 862
2016
Q3 		$158K Buy
+13,398
New +$204K ﹤0.01% 1293
2016
Q1 		– Sell
-26,517
Closed -$759K – 2077
2015
Q4 		$759K Buy
26,517
+7,985
+43% +$221K 0.02% 614
2015
Q3 		$527K Buy
18,532
+4,502
+32% +$166K 0.02% 754
2015
Q2 		$504K Buy
14,030
+4,890
+54% +$152K 0.01% 775
2015
Q1 		$266K Sell
9,140
-15,756
-63% -$417K 0.01% 1121
2014
Q4 		$525K Sell
24,896
-19,892
-44% -$393K 0.02% 697
2014
Q3 		$868K Buy
44,788
+9,536
+27% +$150K 0.03% 364
2014
Q2 		$550K Buy
+35,252
New +$570K 0.02% 480

Other funds holding INSY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return

Paul Tudor Jones's INSY Position: Q1 2019 in Review

Paul Tudor Jones sold out of Insys Therapeutics, Inc. (INSY) in Q1 2019, closing a stake of 25,263 shares — an estimated $88K sold.

Paul Tudor Jones first reported a position in INSY in Q2 2014 and held it in 12 quarters. The position peaked at $868K in Q3 2014. 98 funds tracked by Wall St. Rank hold INSY as of Q1 2019.

  • Paul Tudor Jones reported no remaining Insys Therapeutics, Inc. position as of Q1 2019 after selling out during the quarter.
  • Paul Tudor Jones sold 25,263 Insys Therapeutics, Inc. shares in Q1 2019, an estimated $88K.
  • Paul Tudor Jones first reported a position in Insys Therapeutics, Inc. in Q2 2014 and held it in 12 quarters.
  • Paul Tudor Jones's Insys Therapeutics, Inc. position peaked at $868K in Q3 2014.
  • 98 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q1 2019.

Based on Tudor Investment Corp's 13F filing for Q1 2019, filed 15 May 2019.